MedDataX Logo

Selective Lasertrabeculoplasty and Ocular Hemodynamics in Glaucoma

NCT ID: NCT01363362

Last Updated: 2012-12-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

150 participants

Study Classification

INTERVENTIONAL

Study Start Date

2010-12-31

Study Completion Date

2011-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Selective Laser Trabeculoplasty (SLT) is known to reduce intraocular pressure in glaucoma patients. This study investigates, if there are changes in different ocular hemodynamic parameters prior and after SLT.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Ocular blood flow, ocular pulse amplitude and ocular pulse volume are measured with the Blood Flow Analyzer (Paradigm Medical Industries, Inc.) prior and 3 month after SLT.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glaucoma

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Selective Laser Trabeculoplasty pulsatile ocular blood flow

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

glaucoma patients

Glaucoma patients undergoing selective laser trabeculoplasty for further IOP reduction

Group Type EXPERIMENTAL

Selective Laser Trabeculoplasty

Intervention Type PROCEDURE

360° selective laser trabeculoplasty, 100 non-overlapping spots, energy 0,5-1,2 mJ

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Selective Laser Trabeculoplasty

360° selective laser trabeculoplasty, 100 non-overlapping spots, energy 0,5-1,2 mJ

Intervention Type PROCEDURE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Lasertrabeculoplasty

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* glaucoma patient
* over 18 years
* needs further intraocular pressure regulation

Exclusion Criteria

* age under 18 years
* debilitated
* no glaucoma
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Technische Universität Dresden

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Karin Pillunat

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Lutz E Pillunat, Prof. MD

Role: STUDY_CHAIR

University Eye Clinic Dresden

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Eye Clinic Dresden

Dresden, Saxony, Germany

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SLT/OBF_EK 398122010

Identifier Type: -

Identifier Source: org_study_id